Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Brain activation patterns and cognitive processing speed in patients with pediatric-onset multiple sclerosis.
Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
Catechol-O-Methyltransferase Val158Met Polymorphism (rs4680) Is Associated With Pain in Multiple Sclerosis.
Multiple Sclerosis: Progress, but No Cure.
bFGF Protects Pre-oligodendrocytes from Oxygen/Glucose Deprivation Injury to Ameliorate Demyelination.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study.
Glatiramer acetate-induced lobular panniculitis and skin necrosis.
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.
Warmer outdoor temperature is associated with task-related increased BOLD activation in patients with multiple sclerosis.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Vitamin d as a potential therapy in amyotrophic lateral sclerosis.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training.

Pages